43 related articles for article (PubMed ID: 31332942)
1. Expression of inflammation-mediated cluster of genes as a new marker of canine mammary malignancy.
Pawłowski KM; Homa A; Bulkowska M; Majchrzak K; Motyl T; Król M
Vet Res Commun; 2013 Jun; 37(2):123-31. PubMed ID: 23435839
[TBL] [Abstract][Full Text] [Related]
2. Comparative expression pathway analysis of human and canine mammary tumors.
Uva P; Aurisicchio L; Watters J; Loboda A; Kulkarni A; Castle J; Palombo F; Viti V; Mesiti G; Zappulli V; Marconato L; Abramo F; Ciliberto G; Lahm A; La Monica N; de Rinaldis E
BMC Genomics; 2009 Mar; 10():135. PubMed ID: 19327144
[TBL] [Abstract][Full Text] [Related]
3. Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas.
Ettlin J; Bauer A; Opitz L; Malbon A; Markkanen E
J Mammary Gland Biol Neoplasia; 2023 Jul; 28(1):14. PubMed ID: 37391533
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of mammary gland tumours in male dogs and its weak association with development of testicular tumours: a review.
Tkaczyk-Wlizło A; Kowal K; Śmiech A; Ślaska B
J Appl Genet; 2024 Feb; 65(1):137-153. PubMed ID: 38123735
[TBL] [Abstract][Full Text] [Related]
5. Usability of serum hedgehog signalling proteins as biomarkers in canine mammary carcinomas.
Koo H; Lee S; Kim WH
BMC Vet Res; 2023 Nov; 19(1):231. PubMed ID: 37932728
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer.
Atmane MI; Vigneau AL; Beaudry F; Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2023 Dec; 21(4):634-645. PubMed ID: 37709554
[TBL] [Abstract][Full Text] [Related]
7. Comparative aspects of microRNA expression in canine and human cancers.
Sahabi K; Selvarajah GT; Abdullah R; Cheah YK; Tan GC
J Vet Sci; 2018 Mar; 19(2):162-171. PubMed ID: 28927253
[TBL] [Abstract][Full Text] [Related]
8. Strategies for studying immune and non-immune human and canine mammary gland cancer tumour infiltrate.
Rodríguez-Bejarano OH; Roa L; Vargas-Hernández G; Botero-Espinosa L; Parra-López C; Patarroyo MA
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189064. PubMed ID: 38158026
[TBL] [Abstract][Full Text] [Related]
9. Canine multiple primary tumours: Mammary tubular carcinoma, uterine leiomyosarcoma, and facial sebaceous epithelioma.
Kim SH; Baek YB; Park SI
Vet Med (Praha); 2024 Mar; 69(3):94-98. PubMed ID: 38623156
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study.
Vafaei R; Samadi M; Hosseinzadeh A; Barzaman K; Esmailinejad M; Khaki Z; Farahmand L
Cancer Cell Int; 2022 Jan; 22(1):14. PubMed ID: 35000604
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Expression of p62 in Feline Mammary Carcinoma and Non-Neoplastic Mammary Tissue.
Magi GE; Mariotti F; Pallotta L; Di Cerbo A; Venanzi FM
Animals (Basel); 2022 Aug; 12(15):. PubMed ID: 35953953
[TBL] [Abstract][Full Text] [Related]
12. P62/SQSTM1 beyond Autophagy: Physiological Role and Therapeutic Applications in Laboratory and Domestic Animals.
Sabbieti MG; Marchegiani A; Sufianov AA; Gabai VL; Shneider A; Agas D
Life (Basel); 2022 Apr; 12(4):. PubMed ID: 35455030
[TBL] [Abstract][Full Text] [Related]
13. Increased Expression of Toll-Like Receptor 4 in Skin of Dogs with Discoid Lupus Erythematous (DLE).
Di Cerbo A; Giusti S; Mariotti F; Spaterna A; Rossi G; Magi GE
Animals (Basel); 2021 Apr; 11(4):. PubMed ID: 33917661
[TBL] [Abstract][Full Text] [Related]
14. p62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunity.
Venanzi FM; Gabai V; Mariotti F; Magi GE; Vullo C; Sufianov AA; Kolesnikov SI; Shneider A
Aging (Albany NY); 2019 Nov; 11(22):10711-10722. PubMed ID: 31754084
[TBL] [Abstract][Full Text] [Related]
15. p62/SQSTM1 expression in canine mammary tumours: Evolutionary notes.
Mariotti F; Magi GE; Gavazza A; Vincenzetti S; Komissarov A; Shneider A; Venanzi FM
Vet Comp Oncol; 2019 Dec; 17(4):570-577. PubMed ID: 31332942
[TBL] [Abstract][Full Text] [Related]
16. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis.
Hussain S; Saxena S; Shrivastava S; Mohanty AK; Kumar S; Singh RJ; Kumar A; Wani SA; Gandham RK; Kumar N; Sharma AK; Tiwari AK; Singh RK
PLoS One; 2018; 13(12):e0208656. PubMed ID: 30517191
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
